
1. niger j clin pract. 2018 jan;21(1):87-92. doi: 10.4103/njcp.njcp_368_16.

where fight hepatitis b infection; trends hepatitis b
virus seroprevalence black sea region turkey.

igde fa(1), taskin h(2), igde m(3), yazici z(4), atilla a(5).

author information: 
(1)department family medicine, faculty medicine, ondokuz mayis university, 
turkey.
(2)department microbiology, pediatric allergy clinic, turkey.
(3)department pediatric allergy, pediatric allergy clinic, turkey.
(4)department virology, faculty veterinary, ondokuz mayis university, turkey.
(5)infectious diseases, samsun education research hospital, turkey.

context: determine new strategies complete coverage hepatitis b virus
(hbv) vaccination, every country needs take concern factors infection 
transmission region.
aims: aim study investigate seroprevalence hepatitis b 
among age groups northern turkey using hbsag anti-hbs serological
markers.
materials methods: laboratory records total 101648 patients of
all ages attending tertiary level hospital samsun, black sea coastal city,
between january 2014 may 2016 evaluated retrospectively.
results: hbsag anti-hbs seropositivity found 4% 38.3%,
respectively. significant difference hbsag (χ2 = 209.08; p = 
0.00), anti-hbs (χ2 = 124.12; p = 0.00) seropositivity, immunization status. 
although found statically difference men women (χ2 = 32.2 p =
0.00) hbsag seropositivity, significant difference anti-hbs 
(p = 0.22). 1998, universal infant immunization program changed hbv
epidemiology turkey, resulted apparent trend towards reduced disease
levels. however, prevalence hbv infection still high adolescent and
young adults.
conclusions: therefore, catch-up immunization program, education, follow-up
policy groups, addition routine infant immunization, will
decrease hbv infection rate, reducing morbidity mortality rates, will
help reduce hepatitis b transmission turkey.

doi: 10.4103/njcp.njcp_368_16 
pmid: 29411730  [indexed medline]

